Ulcers due to gout: Presentation of a case and literature review
Úlceras por gota: Presentación de un caso y revisión de la literatura
Article Sidebar
PDF (Español (España))
FLIP
How to Cite
Hernández, J. I., Bonilla, C. E., & López, J. F. (2004). Ulcers due to gout: Presentation of a case and literature review. Journal of Medicine and Surgery Repertoire, 13(2), 61–66. https://doi.org/10.31260/RepertMedCir.v13.n2.2004.344
Section
Review Articles
License terms
Main Article Content
Abstract
Gout is a well-known disease and within its wide spectrum of signs and symptoms, there are some that have rarely been documented; Such is the case that we present today. It is a patient with gout who suffers ulcers in the lower limbs of long evolution. When being known in the internal medicine service of this institution, a biopsy of the lesions described is performed, confirming panniculitis due to gout, this being the fifth case reported in the world literature.
Downloads
Download data is not yet available.
Article Details
References
1. Gerstner, J. Glosario. Rev. Col. Ort Tra. 2002; 16.
2. Kramer HM, Curgan G The association between gout and nephrolithiasis: the nacional health and nutrition examination survey III, 1988-1994. Am. J Kidney Dis 2002; 4: 37-42
3 Emmerson B, Word A. The Management of Gout. The N Engl J Med 1996; 334 (7): 446-51.
4. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risks and consequences in the Normative aging study. Am J Med 1987; 82: 421-26.
5. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout. J Rheumatol 2000; 27: 1045-1050.
6. Waller PC, Ramsay LE. Predicting acute gout in diuretic - treated hypertensive patients. J Hum Hypertens 1989; 3: 457-61.
7. Kelley ' s Reumatologia. Sinovitis por depósito de Cristales. Gota e hiperuricemia. 2003, Madrid, España: v.3 p.1339-76.
8. Bulla F, Restrepo J F, Iglesias A., Palma, F. Paniculitis por gota. Rev Col Reum 2000:7 (4): 391-95.
9. Wortmann RL. Gout and Hyperuricemia. Curr Opin Rheumatol 2002; 14:281-86.
10. Schlesinger N, Schumacher HR Jr. Gout: can management be improved?. Curr Opin Rheumatol 2001; 13:240-44.
11. Durán R, Altahona H, Hernández J.I, Barreto F.J. Seminarios en Medicina Interna. Bogotá; Universidad del Rosario, 1995; 420.
12. Wallace SL, et al. Preliminary criteria for the classiflcation of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
13. Terkeltaub R A Gout. N. Engl J Med 2003, 349 (17): 1647-55.
14. Terkeltaub RA. Pathogenesis and treatment of crystal induced inflammation. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of Rheumatology. 14 th ed. Philadelphia: Lippincot Williams & Wilkins, 2001; v 2; p. 2329-47.
15. Schlesinger N, Detry MA, Holland BK et al. Local ice therapy during bouts of acute gouty arthritis. J Rheumatol 2002; 29:331-34.
16. Axelrod D, Preston S. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988; 31:803-05.
17. Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetinide in the treatment of acute gouty arthritis. J Rheumatol 1994; 21:1325-27.
18. Emmerson, B. The Management of Gout. N England J Med 1996; 334 (7): 445-51.
19. Ferraz MB. An evidence based appraisal of the management of nontophaceous interval gout. J Rheumatol 1995; 22: 1618-19.
20. Insel P. Analgésicos - Antipiréticos, antiinflamatorios y fármacos Antigotosos. En: Goodman & Gilman's Las Bases Farmacológicas de la Terapéutica,. 9' ed. McGraw-Hill Interamericana. v. 1 p 661-705.
21. Pérez-Ruiz F, Calabozo M, Pijoan JI, Herrero AM, RUibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002; 47:356-60.
22. Shahinfar S, Simpson RL, Carides AD et al. S afety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int 1999;56:1879-85.
23. Sica DA, Schoolwerth AC. Uric Acid and losartan. Curr Opin Nephrol Hypertens 2002; 11:475-82.
24. Wurzner G, Gerster JC, Chiolero A, et al. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout. J Hypertens 2001; 19 (10):1855-60.
25. Bomalaski JS, Holtsberg FW, Ensor CM, Clark MA. Uricase formulated with poyetiethylene glycol (Uricase-PEG 20): biochemical rationale and preclinical studies. J Rheumatol 2002; 29:1942-49.
26. Hepburn AL, Kaye SA, Fcher Fenofibrate: a new treatment for hyperuricaemia and gout?. Ann Rheum Dis 2001; 60(10):984-6.
27. Yamamoto T, Moriwaki Y, Takahashi S, et al. Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol. J Rheumatol. 2001; 28 (10): 229497.
28. Hardin T. Fenofibrate and losartan. Ann Rheum Dis, 2003; 62 (6): 497-98.
29. HepbumAL, Feher Gout. N Engl J Med, 2004; 350 (5): 519-20.
30. Niemi, K M. Panniculitis of the legs with urate cristal deposition. Archi Dermatol 1977; 113: 655-6.
31. Le Boit PE, Schneider S. Gout presenting as lobular panniculitis. Am. J Dermatopathol. 1987; 9:334-38.
32. Conejo-M J, Pulpillo, A et al. Panniculitis and ulcers in a young man. Arch Dermatol 1998; 134: 499-504.
2. Kramer HM, Curgan G The association between gout and nephrolithiasis: the nacional health and nutrition examination survey III, 1988-1994. Am. J Kidney Dis 2002; 4: 37-42
3 Emmerson B, Word A. The Management of Gout. The N Engl J Med 1996; 334 (7): 446-51.
4. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risks and consequences in the Normative aging study. Am J Med 1987; 82: 421-26.
5. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout. J Rheumatol 2000; 27: 1045-1050.
6. Waller PC, Ramsay LE. Predicting acute gout in diuretic - treated hypertensive patients. J Hum Hypertens 1989; 3: 457-61.
7. Kelley ' s Reumatologia. Sinovitis por depósito de Cristales. Gota e hiperuricemia. 2003, Madrid, España: v.3 p.1339-76.
8. Bulla F, Restrepo J F, Iglesias A., Palma, F. Paniculitis por gota. Rev Col Reum 2000:7 (4): 391-95.
9. Wortmann RL. Gout and Hyperuricemia. Curr Opin Rheumatol 2002; 14:281-86.
10. Schlesinger N, Schumacher HR Jr. Gout: can management be improved?. Curr Opin Rheumatol 2001; 13:240-44.
11. Durán R, Altahona H, Hernández J.I, Barreto F.J. Seminarios en Medicina Interna. Bogotá; Universidad del Rosario, 1995; 420.
12. Wallace SL, et al. Preliminary criteria for the classiflcation of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
13. Terkeltaub R A Gout. N. Engl J Med 2003, 349 (17): 1647-55.
14. Terkeltaub RA. Pathogenesis and treatment of crystal induced inflammation. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of Rheumatology. 14 th ed. Philadelphia: Lippincot Williams & Wilkins, 2001; v 2; p. 2329-47.
15. Schlesinger N, Detry MA, Holland BK et al. Local ice therapy during bouts of acute gouty arthritis. J Rheumatol 2002; 29:331-34.
16. Axelrod D, Preston S. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988; 31:803-05.
17. Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetinide in the treatment of acute gouty arthritis. J Rheumatol 1994; 21:1325-27.
18. Emmerson, B. The Management of Gout. N England J Med 1996; 334 (7): 445-51.
19. Ferraz MB. An evidence based appraisal of the management of nontophaceous interval gout. J Rheumatol 1995; 22: 1618-19.
20. Insel P. Analgésicos - Antipiréticos, antiinflamatorios y fármacos Antigotosos. En: Goodman & Gilman's Las Bases Farmacológicas de la Terapéutica,. 9' ed. McGraw-Hill Interamericana. v. 1 p 661-705.
21. Pérez-Ruiz F, Calabozo M, Pijoan JI, Herrero AM, RUibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002; 47:356-60.
22. Shahinfar S, Simpson RL, Carides AD et al. S afety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int 1999;56:1879-85.
23. Sica DA, Schoolwerth AC. Uric Acid and losartan. Curr Opin Nephrol Hypertens 2002; 11:475-82.
24. Wurzner G, Gerster JC, Chiolero A, et al. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout. J Hypertens 2001; 19 (10):1855-60.
25. Bomalaski JS, Holtsberg FW, Ensor CM, Clark MA. Uricase formulated with poyetiethylene glycol (Uricase-PEG 20): biochemical rationale and preclinical studies. J Rheumatol 2002; 29:1942-49.
26. Hepburn AL, Kaye SA, Fcher Fenofibrate: a new treatment for hyperuricaemia and gout?. Ann Rheum Dis 2001; 60(10):984-6.
27. Yamamoto T, Moriwaki Y, Takahashi S, et al. Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol. J Rheumatol. 2001; 28 (10): 229497.
28. Hardin T. Fenofibrate and losartan. Ann Rheum Dis, 2003; 62 (6): 497-98.
29. HepbumAL, Feher Gout. N Engl J Med, 2004; 350 (5): 519-20.
30. Niemi, K M. Panniculitis of the legs with urate cristal deposition. Archi Dermatol 1977; 113: 655-6.
31. Le Boit PE, Schneider S. Gout presenting as lobular panniculitis. Am. J Dermatopathol. 1987; 9:334-38.
32. Conejo-M J, Pulpillo, A et al. Panniculitis and ulcers in a young man. Arch Dermatol 1998; 134: 499-504.